Oncolytics Biotech (ONCY) Leadership Strengthens As Pelareorep Advances

Oncolytics Biotech Inc. (NASDAQ:ONCY) shared a enactment update connected January 7, 2026. With the assignment of Dr. Eileen O’Reilly of Memorial Sloan Kettering Cancer Center, Dr. Neil Segal of MSK, and Dr. Van Morris of MD Anderson Cancer Center, the institution expanded its Gastrointestinal (GI) Tumor Scientific Advisory Board. The objective and strategical oversight is strengthened with the move, arsenic the institution advances pelareorep toward registration-enabling trials successful pancreatic, colorectal, and anal cancers. Furthermore, absorption said that the expanded committee sharpens the late-stage improvement strategy for a GI-focused immunotherapy level with ample addressable markets.

This enactment enlargement follows the company’s objective and translational momentum announced earlier successful December. Data successful second-line KRAS-mutant, microsatellite-stable metastatic colorectal cancer, showed a 33% nonsubjective effect complaint compared to a humanities 6-11%. Furthermore, it showed much than doubling of progression-free and wide endurance versus modular therapy. On the translational investigation front, accrued KRAS-specific T-cell responses were reported, which reinforces pelareorep’s mechanistic differentiation.

Oncolytics Biotech Inc. (NASDAQ:ONCY) is focused connected processing pelareorep, an immune-oncolytic microorganism level targeting coagulated tumors and hematologic malignancies. It leverages tumor-selective viral replication to stimulate innate and adaptive anti-cancer immune responses.

While we admit the imaginable of ONCY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 7 Best Rising Tech Stocks to Buy Now and 12 Best Multibagger Stocks to Buy Heading into 2026.

Disclosure: None.